Quarterly report pursuant to Section 13 or 15(d)

CONTRACTS IN PROGESS

v3.22.4
CONTRACTS IN PROGESS
3 Months Ended
Jan. 31, 2023
Contracts In Progess  
CONTRACTS IN PROGESS

NOTE 9 – CONTRACTS IN PROGESS

 

Costs and estimated earnings in excess of billings on uncompleted contracts represent accumulated project expenses and fees which have not been invoiced to customers as of the balance sheet date. These amounts are stated on the consolidated balance sheets as Unbilled Receivables of $650,774 and $602,115 as of January 31, 2023, and October 31, 2022, respectively.

 

Our Deferred Revenue of $673,158 and $790,458 as of January 31, 2023, and October 31, 2022, respectively, consists of billings in excess of costs and revenues received as part of our warranty obligations upon completing a sale, as elaborated further in the last paragraph of this Note.

 

Sales of equipment include a separate performance obligation for warranty, which is treated as deferred revenue, along with extended warranty options which may be optionally purchased by the customer. These amounts are amortized over the relevant obligation period (12 months is our standard warranty or 24, 36 or 60 months for our extended warranty, sold as our Through Life Support (TLS) Package) from the date of delivery. These amounts are stated on the consolidated balance sheets as a component of Deferred Revenue and were $233,700 and $229,238 as of January 31, 2023, and October 31, 2022, respectively.

 

 

CODA OCTOPUS GROUP, INC.

Notes to the Consolidated Financial Statements

January 31, 2023 and October 31, 2022